Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.Science Translational Medicine|November 9, 2022
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustionIn-Young Jung, Vivek Narayan, Sierra McDonald, et al.Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.The Journal of Clinical Investigation|August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesMarco Ruella, David M Barrett, Saad S Kenderian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2021
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical TrialStephan Kadauke, Regina M Myers, Yimei Li, et al.The Journal of Clinical Investigation|March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaAdam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.Cancer Research Communications|June 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast CarcinomaPayal D Shah, Alexander C Huang, Xiaowei Xu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2023
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe-Herranz, Silvia Beghi, Marco Ruella, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.Pageof 11